Your browser doesn't support javascript.
loading
Ceftazidime and cefepime antagonize 5-fluorouracil's effect in colon cancer cells.
Pfab, Christina; Abgaryan, Anush; Danzer, Barbara; Mourtada, Fatme; Ali, Weaam; Gessner, André; El-Najjar, Nahed.
Affiliation
  • Pfab C; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Abgaryan A; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Danzer B; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Mourtada F; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Ali W; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Gessner A; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, 93053, Regensburg, Germany.
  • El-Najjar N; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, 93053, Regensburg, Germany. Nahed.El-Najjar@ukr.de.
BMC Cancer ; 22(1): 125, 2022 Jan 31.
Article in En | MEDLINE | ID: mdl-35100987
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Ceftazidime / Colonic Neoplasms / Fluorouracil / Cefepime / Anti-Bacterial Agents / Antineoplastic Agents Limits: Humans Language: En Journal: BMC Cancer Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Ceftazidime / Colonic Neoplasms / Fluorouracil / Cefepime / Anti-Bacterial Agents / Antineoplastic Agents Limits: Humans Language: En Journal: BMC Cancer Year: 2022 Document type: Article